Angola vs World: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Angola
3.1%
in 2024
World
0.6%
in 2024
Angola rank
5th
World rank
2nd
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Angola
- World
How they compare
Angola currently reports 3.1% against 0.6% in World, a difference of 2.5%.
That makes Angola's figure about 5.2 times World's.
Across all 10 years both countries report, Angola has been ahead every year.
Angola ranks 5th and World ranks 2nd of 215 countries.
Angola has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Angola | World | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.6% | 0.7% | 1.9% | Angola |
| 2020s | 3.0% | 0.6% | 2.4% | Angola |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Angola or World?
- Angola, at 3.1% against 0.6% in World as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Angola and World?
- 2.5%, with Angola ahead.
- How many years of comparable data are there for Angola and World?
- 10 years are reported by both, from 2015 to 2024.
- How do Angola and World rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Angola ranks 5th and World ranks 2nd of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.